/AUSAF
AUSAF Stock - Australis Capital Inc.
Healthcare|Drug Manufacturers - Specialty & GenericOTC
$0.00+0.00%
+$0.00 (+0.00%) • Dec 19
59
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.16
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.100
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.00
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for AUSAF
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.00 – $0.00
TARGET (TP)$0.00
STOP LOSS$0.00
RISK/REWARD1:-1.0
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta-0.55
52W High$0.01
52W Low$0.00
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|
| Revenue | $7.57M | $717,151 | $221,482 | $129,759 | N/A |
| Gross Profit | $3.97M | $-203,000 | $222 | $127,420 | N/A |
| Gross Margin | 52.4% | -28.3% | 0.1% | 98.2% | N/A |
| Operating Income | $-19,382,000 | $-14,035,000 | $-14,398,000 | $-4,294,000 | $-1,041 |
| Net Income | $-50,088,992 | $-25,261,000 | $-23,342,000 | $-4,171,000 | $-42,697 |
| Net Margin | -661.5% | -3522.4% | -10539.0% | -3214.4% | N/A |
| EPS | $-0.16 | $-0.14 | $-0.14 | $-0.04 | $-0.00 |
Company Overview
Australis Capital Inc. operates as a cannabis company. It undertakes cannabis, as well as horticulture projects in the United States, Canada, Denmark Finland, Iceland, Germany, the Netherlands, Bahrein, the United Arab Emirates, Southeast Asia, and Australia, as well as other jurisdictions. The company is based in Las Vegas, Nevada.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
AUSAFBeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$-0.00
Q3 2022
EPS Surprise History
Q3 20
No data
Q3 20
No data
Q4 20
No data
Q2 21
No data
Q3 21
No data
Q4 21
No data
Q1 22
No data
Q3 22
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q3 2024 | Aug 26, 2024 | — | — | — | — |
Q2 2024 | May 14, 2024 | — | — | — | — |
Q1 2024 | Feb 26, 2024 | — | — | — | — |
Q4 2023 | Dec 4, 2023 | — | — | — | — |
Q3 2023 | Sep 22, 2023 | — | — | — | — |
Q2 2023 | Apr 19, 2023 | — | — | — | — |
Q2 2023 | Apr 9, 2023 | — | — | — | — |
Q3 2022 | Aug 2, 2022 | — | $-0.00 | — | — |
Q1 2022 | Mar 1, 2022 | — | $-0.01 | — | — |
Q4 2021 | Nov 22, 2021 | — | $-0.01 | — | — |
Q3 2021 | Jul 8, 2021 | — | $0.01 | — | — |
Q2 2021 | Jun 30, 2021 | — | $-0.03 | — | — |
Q4 2020 | Dec 31, 2020 | — | $-0.09 | — | — |
Q3 2020 | Sep 30, 2020 | — | $-0.03 | — | — |
Q3 2020 | Jul 2, 2020 | — | $-0.05 | — | — |
Q2 2020 | Jun 30, 2020 | — | $-0.02 | — | — |
Q1 2020 | Feb 27, 2020 | — | $-0.03 | — | — |
Q4 2019 | Nov 27, 2019 | — | $-0.03 | — | — |
Q3 2019 | Aug 28, 2019 | — | $-0.01 | — | — |
Q3 2019 | Jul 31, 2019 | — | $-0.00 | — | — |
Latest News
Washington Post Reported President Trump Expected To Announce A Medicare Pilot Program To Reimburse Patients' CBD Treatments
📈 PositiveBenzinga•Dec 18, 2025, 12:21 PM•Also: , ,
'Trump to sign executive order reclassifying marijuana: Officials' -ABC Report
📈 PositiveBenzinga•Dec 17, 2025, 01:38 PM•Also: , ,
Frequently Asked Questions about AUSAF
What is AUSAF's current stock price?
Australis Capital Inc. (AUSAF) is currently trading at $0.00 per share. The stock has moved +0.00% today.
What is the analyst price target for AUSAF?
No analyst price targets are currently available for this stock.
What sector is Australis Capital Inc. in?
Australis Capital Inc. operates in the Healthcare sector, specifically within the Drug Manufacturers - Specialty & Generic industry. The company is traded on the OTC exchange.
What is AUSAF's market cap?
Australis Capital Inc. has a market capitalization of $0.00 billion, making it a small-cap company.
Does AUSAF pay dividends?
No, Australis Capital Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorAYRWF
Ayr Wellness Inc.
$0.05
Mkt Cap: $0.0B
BUDZ
WEED, Inc.
$0.07
Mkt Cap: $0.0B
CBIH
Cannabis Bioscience International Holdings, Inc.
$0.00
Mkt Cap: $0.0B
DHBUF
Delivra Health Brands Inc.
$0.18
Mkt Cap: $0.0B
FAGI
Full Alliance Group, Inc.
$0.07
Mkt Cap: $0.0B
HYEX
Healthy Extracts Inc.
$1.91
Mkt Cap: $0.0B
IONKF
Ionic Brands Corp.
$0.00
Mkt Cap: $0.0B
LOBEF
Lobe Sciences Ltd.
$0.00
Mkt Cap: $0.0B
RPNRF
Rapid Nutrition PLC
$0.01
Mkt Cap: $0.0B
TWSI
Tristar Wellness Solutions Inc.
$0.17
Mkt Cap: $0.0B
Explore stocks similar to AUSAF for comparison